Jaguar Health, Inc. Cash Flow Statement
JAGX|9 years of annual SEC 10-K data (FY2015-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
Jaguar Health, Inc. used $29M in operating cash flow and negative free cash flow of $29M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2022 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$38.5M | -$41.3M | -$52.6M | -$38.5M | -$32.1M | -$22.0M | -$14.7M | -$16.3M | -$8.6M |
| Depreciation & Amortization | $1.9M | $2.0M | $1.7M | $1.7M | $1.3M | $584.3K | $47.5K | $5.2K | $5.2K |
| Operating Cash Flow | -$29.4M | -$33.2M | -$35.0M | -$20.5M | -$22.7M | -$9.8M | -$14.4M | -$14.3M | -$5.4M |
| Capital Expenditures | $16.0K | $16.0K | $6.0K | $7.0K | $6.5K | $6.5K | $104.2K | $23.3K | $55.1K |
| Free Cash Flow | -$29.4M | -$33.3M | -$35.0M | -$20.5M | -$22.7M | -$9.8M | -$14.5M | -$14.3M | -$5.4M |
| Share Buybacks | - | - | - | - | $30 | $30 | - | - | - |
| FCF Margin | -251.5% | -340.7% | -806.8% | -354.3% | -514.9% | -225.4% | -10258.4% | -5549.6% | - |